Barclays’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $329K | Sell |
|
|||||
|
2025
Q2 | $434K | Sell |
|
|||||
|
2025
Q1 | $403K | Buy |
|
|||||
|
2024
Q4 | $313K | Buy |
|
|||||
|
2024
Q3 | $348K | Sell |
|
|||||
|
2024
Q2 | $324K | Buy |
|
|||||
|
2024
Q1 | $409K | Sell |
|
|||||
|
2023
Q4 | $850K | Sell |
|
|||||
|
2023
Q3 | $1.56M | Buy |
|
|||||
|
2023
Q2 | $748K | Hold |
|
|||||
|
2023
Q1 | $523K | Hold |
|
|||||
|
2022
Q4 | $572K | Buy |
|
|||||
|
2022
Q3 | $11K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $9K | Sell |
|
|||||
|
2021
Q2 | $47K | Sell |
|
|||||
|
2021
Q1 | $95K | Sell |
|
|||||
|
2020
Q4 | $128K | Sell |
|
|||||
|
2020
Q3 | $131K | Sell |
|
|||||
|
2020
Q2 | $597K | Buy |
|
|||||
|
2020
Q1 | $394K | Buy |
|
|||||
|
2019
Q4 | $522K | Buy |
|
|||||
|
2019
Q3 | $131K | Buy |
|
|||||
|
2019
Q2 | $123K | Buy |
|
|||||
|
2019
Q1 | $99K | Sell |
|
|||||
|
2018
Q4 | $450K | Buy |
|
|||||
|
2018
Q3 | $283K | Buy |
|
|||||
|
2018
Q2 | $58K | Sell |
|
|||||
|
2018
Q1 | $132K | Sell |
|
|||||
|
2017
Q4 | $341K | Sell |
|
|||||
|
2017
Q3 | $3.44M | Buy |
|
|||||
|
2017
Q2 | $7K | Sell |
|
|||||
|
2017
Q1 | $131K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $0 | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $1K | Buy |
|